Ceftazidime for Injection, USP
... As with other antibiotics, prolonged use of ceftazidime may result in overgrowth of nonsusceptible organisms. Repeated evaluation of the patient’s condition is essential. If superinfection occurs during therapy, appropriate measures should be taken. Inducible type I beta-lactamase resistance has bee ...
... As with other antibiotics, prolonged use of ceftazidime may result in overgrowth of nonsusceptible organisms. Repeated evaluation of the patient’s condition is essential. If superinfection occurs during therapy, appropriate measures should be taken. Inducible type I beta-lactamase resistance has bee ...
METHOTREXAT “EBEWE” 10 mg/ml and 100 mg/ml
... In the case of high dose of methotrexate the creatinine clearance should be at least 75% of the normal value (50 ml/min/m2 resp. 90 ml/min). An intermediate dose of methotrexate (> 100 mg/m2) should not be prescribed if the creatinine clearance is reduced below 50% of the normal value (< 35 ml/min/m ...
... In the case of high dose of methotrexate the creatinine clearance should be at least 75% of the normal value (50 ml/min/m2 resp. 90 ml/min). An intermediate dose of methotrexate (> 100 mg/m2) should not be prescribed if the creatinine clearance is reduced below 50% of the normal value (< 35 ml/min/m ...
as a PDF
... alone in the absence of evidence of intermittent bronchial obstruction is unlikely to be caused by asthma. Allergic bronchopulmonary aspergillosis and pulmonary eosinophilic syndromes may be considered unique diseases with some of the clinical features of asthma and are often difficult to treat; the ...
... alone in the absence of evidence of intermittent bronchial obstruction is unlikely to be caused by asthma. Allergic bronchopulmonary aspergillosis and pulmonary eosinophilic syndromes may be considered unique diseases with some of the clinical features of asthma and are often difficult to treat; the ...
immunochemical mechanisms involved in penicillin hypersensitivity
... (1) Benzylpenicilloyl-specific antibodies were detected by direct skin tests (Levine and Ovary, 1961; Levine and Price, 1964; Parker, Shapiro, Kern and Eisen, 1962) and by passive transfer techniques (Siegal and Levine, 1964). Skin test reagents which can be used for detection of benzylpenicilloyl ( ...
... (1) Benzylpenicilloyl-specific antibodies were detected by direct skin tests (Levine and Ovary, 1961; Levine and Price, 1964; Parker, Shapiro, Kern and Eisen, 1962) and by passive transfer techniques (Siegal and Levine, 1964). Skin test reagents which can be used for detection of benzylpenicilloyl ( ...
515 abstracts
... (1967-2009). RCTs were included if subjects had consumed alcohol immediately prior to or during the study, were administered acetaminophen in therapeutic doses (up to 4 g daily), and compared ALT levels between placebo and treatment groups. Data were abstracted by two independent reviewers. The prim ...
... (1967-2009). RCTs were included if subjects had consumed alcohol immediately prior to or during the study, were administered acetaminophen in therapeutic doses (up to 4 g daily), and compared ALT levels between placebo and treatment groups. Data were abstracted by two independent reviewers. The prim ...
Rahko, Marc A. Silver, Lynne Warner Stevenson and
... from both organizations and charged with examining subject-specific data and writing or updating these guidelines. The process includes additional representatives from other medical practitioner and specialty groups where appropriate. Writing groups are specifically charged to perform a formal liter ...
... from both organizations and charged with examining subject-specific data and writing or updating these guidelines. The process includes additional representatives from other medical practitioner and specialty groups where appropriate. Writing groups are specifically charged to perform a formal liter ...
recommendations - Toward Optimized Practice
... precipitously without a viral prodrome.33 This latter type of croup is not characterized by fever, and symptoms are thought to be more transient than in children with acute LTB. Children with spasmodic croup are also thought to have recurrent episodes. Though these types of croup are generally descr ...
... precipitously without a viral prodrome.33 This latter type of croup is not characterized by fever, and symptoms are thought to be more transient than in children with acute LTB. Children with spasmodic croup are also thought to have recurrent episodes. Though these types of croup are generally descr ...
2009 Focused Update Incorporated Into ACC/AHA 2005 Guidelines
... (UPDATED) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .e433 4.4.4. Mechanical and Surgical Strategies . . . . . . . . . . .e434 4.5. The Hospitalized Patient (NEW) . . . . . . . . . . . . . . . . . .e435 4.5.1. Diagnostic Strategies. . . . . . . . . . . . . . . . . . . . . . ...
... (UPDATED) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .e433 4.4.4. Mechanical and Surgical Strategies . . . . . . . . . . .e434 4.5. The Hospitalized Patient (NEW) . . . . . . . . . . . . . . . . . .e435 4.5.1. Diagnostic Strategies. . . . . . . . . . . . . . . . . . . . . . ...
2014 Abstracts - The American Academy of Clinical Toxicology
... Background: Ondansetron is a commonly used antiemetic that has been linked to QT interval prolongation. Prolongation of the QT interval may result in tachyarrhythmias, including torsades de pointes, potentially placing patients at risk for sudden cardiac death. To date, it is not clear whether ondan ...
... Background: Ondansetron is a commonly used antiemetic that has been linked to QT interval prolongation. Prolongation of the QT interval may result in tachyarrhythmias, including torsades de pointes, potentially placing patients at risk for sudden cardiac death. To date, it is not clear whether ondan ...
Zyprexa - Eli Lilly and Company
... discontinuation and close monitoring. (5.3) Metabolic Changes: Atypical antipsychotic drugs have been associated with metabolic changes including hyperglycemia, dyslipidemia, and weight gain. (5.4) • Hyperglycemia and Diabetes Mellitus: In some cases extreme and associated with ketoacidosis or hyper ...
... discontinuation and close monitoring. (5.3) Metabolic Changes: Atypical antipsychotic drugs have been associated with metabolic changes including hyperglycemia, dyslipidemia, and weight gain. (5.4) • Hyperglycemia and Diabetes Mellitus: In some cases extreme and associated with ketoacidosis or hyper ...
Docetaxel Ebewe, Concentrate for injection
... chemotherapy. Docetaxel 75 mg/m2 was administered on day 2 of cycle 1, then on day 1 of all subsequent cycles by IV infusion over 1 hour followed by carboplatin (AUC 6 mg/mL/min) as a 30-60 minute IV infusion, for a total of six cycles of docetaxel and carboplatin. Beginning three weeks after the la ...
... chemotherapy. Docetaxel 75 mg/m2 was administered on day 2 of cycle 1, then on day 1 of all subsequent cycles by IV infusion over 1 hour followed by carboplatin (AUC 6 mg/mL/min) as a 30-60 minute IV infusion, for a total of six cycles of docetaxel and carboplatin. Beginning three weeks after the la ...
Manifestations of Syphilis
... crystalline penicillin G, 2 to 4 million units intravenously every 4 hours for 10 to 14 days.16 Penicillin allergy poses a problem in the treatment of syphilis. For treatment of neurosyphilis, it has been suggested that penicillin-allergic patients be desensitized in order to receive standard drug t ...
... crystalline penicillin G, 2 to 4 million units intravenously every 4 hours for 10 to 14 days.16 Penicillin allergy poses a problem in the treatment of syphilis. For treatment of neurosyphilis, it has been suggested that penicillin-allergic patients be desensitized in order to receive standard drug t ...
PRODUCT MONOGRAPH Pr OMNITROPE TM
... The subcutaneous administration of growth hormone at the same injection site over a long period may result in local lipoatrophy. ...
... The subcutaneous administration of growth hormone at the same injection site over a long period may result in local lipoatrophy. ...
Awareness Toolkit for Patients - Foundation for Sarcoidosis Research
... • Determine if there is an application process for proclamations • Is the application online? Do you submit the request by mail? • What is the timeline for securing a proclamation? • Contact the office of your elected officials. Inquire about the process of obtaining a proclamation, if the infor ...
... • Determine if there is an application process for proclamations • Is the application online? Do you submit the request by mail? • What is the timeline for securing a proclamation? • Contact the office of your elected officials. Inquire about the process of obtaining a proclamation, if the infor ...
Preseptal and Orbital Cellulitis: A 10
... orbital cellulitis were also admitted. In addition, patients with neurologic signs or symptoms (e.g. drowsiness, nausea/vomiting, headaches, seizures, or cranial nerve lesion) or poor compliance who required further examinations were also hospitalized. Radiologic study was indicated if full evaluati ...
... orbital cellulitis were also admitted. In addition, patients with neurologic signs or symptoms (e.g. drowsiness, nausea/vomiting, headaches, seizures, or cranial nerve lesion) or poor compliance who required further examinations were also hospitalized. Radiologic study was indicated if full evaluati ...
Abnormal Uterine Bleeding and Uterine Fibroids
... bleeding. No other differences between treatments were found. The review group concluded that less-invasive treatment options for AUB result in improvement in quality of life but carry significant risk of retreatment caused by unsatisfactory results. Although hysterectomy is the most effective treat ...
... bleeding. No other differences between treatments were found. The review group concluded that less-invasive treatment options for AUB result in improvement in quality of life but carry significant risk of retreatment caused by unsatisfactory results. Although hysterectomy is the most effective treat ...
Ipratropium Bromide Inhalation Solution 0.02%
... inhalation solution administered either alone or with other bronchodilators, especially beta adrenergics, is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. CONTRAINDICATIONS Ip ...
... inhalation solution administered either alone or with other bronchodilators, especially beta adrenergics, is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. CONTRAINDICATIONS Ip ...
ACCF/AHA Practice Guideline: Full Text
... the ACCF/AHA Task Force on Practice Guidelines, whose charge is to develop and revise practice guidelines for important cardiovascular diseases and procedures. Experts in the subject under consideration are selected from both organizations and charged with examining subject-specific data and writing ...
... the ACCF/AHA Task Force on Practice Guidelines, whose charge is to develop and revise practice guidelines for important cardiovascular diseases and procedures. Experts in the subject under consideration are selected from both organizations and charged with examining subject-specific data and writing ...
Diagnostic Evaluation of Infants with Recurrent or Persistent
... 50% of patients. Recurrent laryngeal nerve injury was the most common surgical complication and occurred in less than 10% of patients. More serious complications such as aortoesophageal fistula, heart failure, or wound infection associated with mortality occurred in less than 5% of patients (44-50). ...
... 50% of patients. Recurrent laryngeal nerve injury was the most common surgical complication and occurred in less than 10% of patients. More serious complications such as aortoesophageal fistula, heart failure, or wound infection associated with mortality occurred in less than 5% of patients (44-50). ...
Asthma - NYSCHA
... increasing (some estimates of up to 25% among urban kids) 5/10/06 Asthma is declared the most common chronic childhood disease # of visits with asthma as primary diagnosis 13.3 mil Mortality about 4000 per year Deaths per 100000 population 1.1 ...
... increasing (some estimates of up to 25% among urban kids) 5/10/06 Asthma is declared the most common chronic childhood disease # of visits with asthma as primary diagnosis 13.3 mil Mortality about 4000 per year Deaths per 100000 population 1.1 ...
Microglia and neurodegeneration C Cummingham
... genetic predisposition, to respond more vigorously to subsequent inflammatory stimulation, thus transforming an adaptive CNS inflammatory response to systemic inflammation, into one that has deleterious consequences for the individual. In this review, the preclinical and clinical evidence supporting ...
... genetic predisposition, to respond more vigorously to subsequent inflammatory stimulation, thus transforming an adaptive CNS inflammatory response to systemic inflammation, into one that has deleterious consequences for the individual. In this review, the preclinical and clinical evidence supporting ...
Immune-Mediated Adverse Reactions Management Guide
... This section contains guidance for the management of select immune-mediated adverse reactions, which includes adverse reaction management algorithms from the clinical trials of OPDIVO® and the OPDIVO + YERVOY® Regimen.1,2 For ease of use, this guidance is organized by body system and contains both m ...
... This section contains guidance for the management of select immune-mediated adverse reactions, which includes adverse reaction management algorithms from the clinical trials of OPDIVO® and the OPDIVO + YERVOY® Regimen.1,2 For ease of use, this guidance is organized by body system and contains both m ...
PRODUCT INFORMATION QUETIAPINE SANDOZ® 25/100/200
... Quetiapine is extensively metabolised by the liver following oral administration, with parent compound accounting for less than 5% of unchanged drug related material in the urine or faeces, following the administration of radiolabelled quetiapine. The average molar dose fraction of free quetiapine a ...
... Quetiapine is extensively metabolised by the liver following oral administration, with parent compound accounting for less than 5% of unchanged drug related material in the urine or faeces, following the administration of radiolabelled quetiapine. The average molar dose fraction of free quetiapine a ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.